Activation of AMPK/proteasome/MLCK degradation signaling axis by telmisartan inhibits VSMC contractility and vessel contraction
Yun‐Jin Hwang, Du‐Hyong Cho
Topics & Concepts
TelmisartanMyosin light-chain kinaseEndocrinologyInternal medicineContractilityAMPKPhosphorylationAngiotensin IIChemistryVascular smooth muscleProtein kinase AReceptorBiologyMedicineBiochemistryBlood pressureSmooth muscleNitric Oxide and Endothelin EffectsMetabolism, Diabetes, and CancerProtein Kinase Regulation and GTPase Signaling